Latest Acquisition Lands AxoSim in the News
On Tuesday, October 24, 2023, AxoSim announced the completion of its acquisition of the microBrain™-associated assets of Vyant Bio’s StemoniX […]
Latest Acquisition Lands AxoSim in the News Read more
On Tuesday, October 24, 2023, AxoSim announced the completion of its acquisition of the microBrain™-associated assets of Vyant Bio’s StemoniX […]
Latest Acquisition Lands AxoSim in the News Read more
–Two grants from the DoD Congressionally Directed Medical Research Program and the National Institutes of Health awarded to AxoSim– –The
AxoSim Announces the Award of over $870,000 in Federal Grants Read more